Expression of cyclin-dependent kinases and their clinical significance with immune infiltrates could predict prognosis in colorectal cancer
Open Access
- 1 March 2021
- journal article
- research article
- Published by Elsevier in Biotechnology Reports
- Vol. 29, e00602
Abstract
No abstract availableKeywords
This publication has 74 references indexed in Scilit:
- Brain-Derived Neurotrophic Factor-Dependent cdk1 Inhibition Prevents G2/M Progression in Differentiating Tetraploid NeuronsPLOS ONE, 2013
- CDK4: A Key Player in the Cell Cycle, Development, and CancerGenes & Cancer, 2012
- Recurrent R-spondin fusions in colon cancerNature, 2012
- Comprehensive molecular characterization of human colon and rectal cancerNature, 2012
- Specific activity of cyclin-dependent kinase I is a new potential predictor of tumour recurrence in stage II colon cancerBritish Journal of Cancer, 2011
- Expression ratio of CCND1 to CDKN2A mRNA predicts RB1 status of cultured cancer cell lines and clinical tumor samplesMolecular Cancer, 2011
- Cdk1/Cyclin B1 Controls Fas-Mediated Apoptosis by Regulating Caspase-8 ActivityMolecular and Cellular Biology, 2010
- Mutated KRAS results in overexpression of DUSP4, a MAP‐kinase phosphatase, and SMYD3, a histone methyltransferase, in rectal carcinomasGenes, Chromosomes and Cancer, 2010
- Transcriptome Profile of Human Colorectal AdenomasMolecular Cancer Research, 2007
- Cdk1 is sufficient to drive the mammalian cell cycleNature, 2007